PPT-Updated 2011 WHO Rubella Vaccine Position Paper and Implica

Author : marina-yarberry | Published Date : 2017-11-14

10 th Measles Initiative Meeting September 1314 2011 Washington DC Susan E Reef CDCGIDDEEB Peter M Strebel WHOHQIVBEPI Outline Global and regional status CRS burden

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Updated 2011 WHO Rubella Vaccine Positio..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Updated 2011 WHO Rubella Vaccine Position Paper and Implica: Transcript

10 th Measles Initiative Meeting September 1314 2011 Washington DC Susan E Reef CDCGIDDEEB Peter M Strebel WHOHQIVBEPI Outline Global and regional status CRS burden Vaccine uptake and regional goals. --Who We Are--. Stephen Cochi, . MD, MPH. Global . Immunization Division. Centers . for . Disease Control & Prevention. What is the Measles & Rubella Initiative? . Anne Ray Charitable Trust. Panel 01502. Vicki Stambos. The 13. th. Global Measles and Rubella Laboratory Network Meeting, Geneva, Switzerland, 29. th. June to 1. st. July 2015. Vicki Stambos. Accelerating Progress Towards Measles and Rubella Control and Elimination Meeting. Regional MR TAG . Nairobi, Kenya . June 2-3 , 2015 . Outline . Background . Epidemiology of Rubella . Strategic options for rubella control AFR . MR introduction progress noted issues related to MR introduction in AFR . Dr. Kimberly M. Thompson. Kid Risk, Inc., www.kidrisk.org. Topics. Context. I. ntegrated dynamic disease and economic . modeling. Discussion. http://www.wpro.who.int/vietnam/topics/immunization/measles_rubella/measles_rubella_big.png?ua=1. M&RI Partners’ Meeting. Michael F Thomas, . Director Vaccine Implementation. September 2017, Washington DC. Page: . 1. Reach every child. . Measles and Rubella support in Gavi countries by end of 2016. 2020. . Summary of the . Findings . and Implementation Status . Dr Kaushik . Banerjee. M&RI Partners' Meeting. Washington DC. 7 September 2017. 1. Objectives . of . the Review. To provide a candid review of progress . South East Asia Region. 1. 21 June 2016. Geneva, Switzerland. Regional Measles and Rubella Goals. 66th Meeting of the SEAR Regional Committee in September 2013 in New Delhi resolved . to adopt . the goal of . Hotel Royal, Geneva, Switzerland, 21-23 June 2016. Paul Rota,. Measles, Mumps, Rubella, Herpesviruses Laboratory Branch, CDC . par1@cdc.gov. . National Center for Immunization & Respiratory Diseases. in . Low. -Resource Settings: . Limitations. , Biases, and . Potential . for Strengthening. Amy Winter, PhD Candidate, Princeton University. Advisor:. Jess Metcalf. Assistant Professor of Ecology and . MEA R) VACCINE What is the measles, mump and rubella (MMR) vaccine? The MMR vaccine protects against three diseases: measles, mumps and rubella (german measles). The vaccine is approved by He alth C 1 In some circumstances, advice in these guidelines may differ from that in the Summary of Product Characteristics of the vaccines. When this occurs, the recommendations in these guidelines, which are 10. th. Measles Initiative Meeting. September 13-14, 2011, . Washington DC. Susan. E. Reef, CDC/GID/DEEB. Peter M. Strebel, WHO/HQ/IVB/EPI. Outline. Global and regional status . CRS burden. Vaccine uptake and regional goals. Opening Comments & Perspectives. Dr. Suresh Jadhav. Executive Director. Serum Institute of India Pvt. Ltd.,. ssj@seruminstitute.com. . We, at Serum Institute of India Pvt. Ltd., feel proud of being a partner to PAHO / WHO in achieving what is designated to be a historical achievement in eradication of Measles & Rubella diseases from the Americas.. .. Education Department.. Kolkata. . Measles . - . An acute viral infection spread via respiratory secretions or aerosols. leading causes of death . among young children . even though a safe and cost-effective vaccine is available.

Download Document

Here is the link to download the presentation.
"Updated 2011 WHO Rubella Vaccine Position Paper and Implica"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.